Lori A. Erickson

8.5k total citations · 3 hit papers
185 papers, 5.5k citations indexed

About

Lori A. Erickson is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Lori A. Erickson has authored 185 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Oncology, 47 papers in Surgery and 42 papers in Molecular Biology. Recurrent topics in Lori A. Erickson's work include Thyroid Cancer Diagnosis and Treatment (24 papers), Cutaneous Melanoma Detection and Management (17 papers) and Sarcoma Diagnosis and Treatment (17 papers). Lori A. Erickson is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (24 papers), Cutaneous Melanoma Detection and Management (17 papers) and Sarcoma Diagnosis and Treatment (17 papers). Lori A. Erickson collaborates with scholars based in United States, Italy and Canada. Lori A. Erickson's co-authors include Ricardo V. Lloyd, Long Jin, Svetomir N. Markovic, Xiang Qian, John C. Cheville, Özgür Mete, Geoffrey B. Thompson, Bernd W. Scheithauer, Elzbieta Kulig and C. Christofer Juhlin and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Lori A. Erickson

164 papers receiving 5.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

p27kip1: A Multifunctional Cyclin-Dependent Kinase Inhibitor with Prognostic Significance in Human Cancers

1999 517 citations Ricardo V. Lloyd, Lori A. Erickson et al. profile →
Overview of the 2022 WHO Classification of Adrenal Cortical Tumors

2022 150 citations Özgür Mete, Lori A. Erickson et al. Endocrine Pathology profile →
Overview of the 2022 WHO Classification of Parathyroid Tumors

2022 133 citations Lori A. Erickson, Özgür Mete et al. Endocrine Pathology profile →

Peers

Countries citing papers authored by Lori A. Erickson

Since Specialization

Citations

This map shows the geographic impact of Lori A. Erickson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lori A. Erickson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lori A. Erickson more than expected).

Fields of papers citing papers by Lori A. Erickson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lori A. Erickson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lori A. Erickson. The network helps show where Lori A. Erickson may publish in the future.

Co-authorship network of co-authors of Lori A. Erickson

This figure shows the co-authorship network connecting the top 25 collaborators of Lori A. Erickson. A scholar is included among the top collaborators of Lori A. Erickson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lori A. Erickson. Lori A. Erickson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Selected updates in thyroid, parathyroid, and adrenal gland pathology 2026 ·Human Pathology ·Lori A. Erickson, Sounak Gupta, Rumeal D. Whaley, (unknown), (unknown)	0
2	Human Papillomavirus–Associated Penile Squamous Cell Carcinoma 2025 ·Mayo Clinic Proceedings ·Burak Tekin, Lori A. Erickson, Sounak Gupta	1
3	Large-Cell Calcifying Sertoli Cell Tumor 2024 ·Mayo Clinic Proceedings ·Sounak Gupta, Lori A. Erickson	1
4	Re: p53 Immunohistochemistry Defines a Subset of Human Papillomavirus–Independent Penile Squamous Cell Carcinomas With Adverse Prognosis 2024 ·The American Journal of Surgical Pathology ·Burak Tekin, (unknown), Lori A. Erickson, John C. Cheville, Sounak Gupta	1
5	Gynecologic-Type Adenocarcinoma With Mixed Serous and Endometrioid Features in a Male Patient 2023 ·Mayo Clinic Proceedings ·Sounak Gupta, J. Kenneth Schoolmeester, Lori A. Erickson	0
6	The Spectrum of Endocrine Pathology 2023 ·Endocrine Pathology ·L. Sylvia, Lori A. Erickson, Guido Rindi	4
7	Overview of the 2022 WHO Classification of Adrenal Cortical Tumors breakdown → 2022 ·Endocrine Pathology ·Özgür Mete, Lori A. Erickson, C. Christofer Juhlin, Ronald R. de Krijger, Hironobu Sasano, Marco Volante, Mauro Papotti	150
8	Renal Neoplasia in Hyperparathyroidism–Jaw Tumor Syndrome 2021 ·Mayo Clinic Proceedings ·Sounak Gupta, Lori A. Erickson	4
9	Correlation of novel ALK^ATI with ALK immunohistochemistry and clinical outcomes in metastatic melanoma 2020 ·Histopathology ·Kabeer Shah, Jadee Neff, Lori A. Erickson, (unknown), Sarah M. Jenkins, Aaron S. Mansfield, Justin C. Moser, (unknown), John A. Copland, Kevin C. Halling, Thomas J. Flotte	5
10	Hepatic Focal Nodular Hyperplasia 2020 ·Mayo Clinic Proceedings ·Lori A. Erickson, Michael Torbenson	4
11	Mutational Profile in Vulvar, Vaginal, and Urethral Melanomas: Review of 37 Cases With Focus on Primary Tumor Site 2019 ·International Journal of Gynecological Pathology ·Shabnam Zarei, Jesse S. Voss, (unknown), (unknown), Alan H. Bryce, Lori A. Erickson, Debra A. Bell, Benjamin R. Kipp, Thomas J. Flotte	21
12	Lipoma 2019 ·Mayo Clinic Proceedings ·Lori A. Erickson	1
13	Desmoid Tumor 2018 ·Mayo Clinic Proceedings ·Meryl C. Nath, Michael Torbenson, Lori A. Erickson	4
14	Gastric Signet Ring Cell Carcinoma 2017 ·Mayo Clinic Proceedings ·Lori A. Erickson	4
15	Parkinson Disease 2016 ·Mayo Clinic Proceedings ·Rachael A. Vaubel, Aditya Raghunathan, Lori A. Erickson	2
16	Prognostic features, human papillomavirus status, and epidermal growth factor receptor expression in oral squamous cell carcinoma in young adults 2012 ·American Journal of Otolaryngology ·Ligy Thomas, Eric J. Moore, Michaela E. McGree, Kerry D. Olsen, Jan L. Kasperbauer, Lori A. Erickson, David Schembri‐Wismayer	17
17	Circulating Serologic and Molecular Biomarkers in Malignant Melanoma 2011 ·Mayo Clinic Proceedings ·(unknown), Lori A. Erickson, Ilia Ichetovkin, Daniel J. Knauer, Svetomir N. Markovic	77
18	Immunohistochemical Separation of Follicular Variant of Papillary Thyroid Carcinoma from Follicular Adenoma 2006 ·Endocrine Pathology ·Nobuki Nakamura, Lori A. Erickson, Long Jin, Sabine Kajita, Heyu Zhang, Xiang Qian, Kandelaria M. Rumilla, Ricardo V. Lloyd	47
19	Association of DNA methylation and epigenetic inactivation of RASSF1A and beta-catenin with metastasis in small bowel carcinoid tumors 2006 ·Endocrine ·(unknown), Kandelaria M. Rumilla, Long Jin, Nobuki Nakamura, Gail A. Stilling, Katharina H. Ruebel, Timothy J. Hobday, Charles Erlichman, Lori A. Erickson, Ricardo V. Lloyd	56
20	p27kip1 Expression Distinguishes Papillary Hyperplasia in Graves' Disease from Papillary Thyroid Carcinoma 2000 ·Modern Pathology ·Lori A. Erickson, (unknown), Long Jin, Christine M. Lohse, V. Shane Pankratz, Ricardo V. Lloyd	32

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact